Last updated: May 29, 2026

Application No. 17/774,111

HUMANIZED ANTI-CA IX ANTIBODIES AND METHODS OF THEIR USE

Non-Final OA

Filed

May 03, 2022

Priority

Nov 05, 2019 — IN PCT/IB2019/059492 +1 more

Examiner

YAO, LEI

Art Unit

1642

Tech Center

1600 — Biotechnology & Organic Chemistry

Assignee

Mabpro A S

OA Round

1 (Non-Final)

This examiner grants 60% of cases after interview

— +65.6% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.

Based on 853 resolved cases, 2023–2026

Examiner Intelligence

YAO, LEI View full profile →

Grants 60% of resolved cases

Career Allowance Rate

512 granted / 853 resolved

At TC average

Strong +66% interview lift

Without

With

+65.6%

Interview Lift

resolved cases with interview

Typical timeline

3y 4m

Avg Prosecution

27 currently pending

Career history

878

Total Applications

across all art units

Statute-Specific Performance

§101

2.1%

-37.9% vs TC avg

§103

42.3%

+2.3% vs TC avg

§102

10.6%

-29.4% vs TC avg

§112

16.7%

-23.3% vs TC avg

Black line = Tech Center average estimate • Based on career data from 853 resolved cases

Prosecution Timeline

May 03, 2022

Application Filed

Sep 12, 2025

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

19/311,965

Patent 12637519

Subcutaneous Formulations Of Anti-CD38 Antibodies And Their Uses

9m to grant Granted May 26, 2026

17/851,930

Patent 12624108

ANTI-GALECTIN-9 ANTIBODIES AND USES THEREOF

3y 10m to grant Granted May 12, 2026

17/997,720

Patent 12624092

COMPOSITIONS AND METHODS FOR MEMBRANE PROTEIN STRUCTURE DETERMINATION

3y 6m to grant Granted May 12, 2026

17/739,934

Patent 12617854

HUMANIZED OR CHIMERIC CD3 ANTIBODIES

3y 12m to grant Granted May 05, 2026

17/747,591

Patent 12590968

DETECTION AND TREATMENT OF CD30+ CANCERS

3y 10m to grant Granted Mar 31, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

60%

Grant Probability

99%

With Interview (+65.6%)

3y 4m (~0m remaining)

Median Time to Grant

Low

PTA Risk

Based on 853 resolved cases by this examiner. Grant probability derived from career allowance rate.